Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/117320
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKorça, Edina-
dc.contributor.authorKanaan, Jad-
dc.contributor.authorBenke, Kálmán-
dc.contributor.authorVeres, Gábor-
dc.contributor.authorMichaelsen, Jens Kersten-
dc.contributor.authorSzabó, Gábor-
dc.date.accessioned2024-12-02T12:43:53Z-
dc.date.available2024-12-02T12:43:53Z-
dc.date.issued2022-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/119279-
dc.identifier.urihttp://dx.doi.org/10.25673/117320-
dc.description.abstractBackground: Angiosarcomas are the most common malignant tumors of the heart and great vessels. Late onset and unspecific symptoms are reasons why a diagnosis is made rather late at a time when most tumors have already metastasized. We report a rare case of an angiosarcoma presenting as pulmonary artery emboli. Case presentation: A 66-year-old patient was initially admitted to the hospital with a STEMI. Days later a successful reanimation due to ventricular fibrillation followed. An emboli of the pulmonary artery was diagnosed as the cause and after a lysis therapy the patient was discharged. A few weeks later the patient suffered an episode of absolute arrhythmia. TTE as well as CT-Scan showed an emboli of the pulmonary artery and a pericardial effusion with compression to the right ventricle. Intraoperative findings, showed an infiltrating tumor of the pulmonary artery, the pulmonary valve, the RVOT, the LA and LV. A resection of the tumor from the pulmonary artery, valve and RVOT was carried out. A new pulmonary valve was implanted with the reconstruction of the RVOT and pulmonary artery. Due to LV infiltration, only a palliative surgical approach was possible. Despite an uncomplicated postoperative course, the patient died at home two months later. Conclusion: Although a rarity, a tumor of the pulmonary artery should be taken into consideration as a differential diagnosis to pulmonary artery emboli. Development of better diagnostic tools (specific tumor markers) and more effective chemotherapeutic agents is necessary to improve the prognosis of these patients.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleCase report : angiosarcoma of the pulmonary artery diagnosed as pulmonary artery embolieng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleJournal of cardiothoracic surgery-
local.bibliographicCitation.volume17-
local.bibliographicCitation.pagestart1-
local.bibliographicCitation.pageend4-
local.bibliographicCitation.publishernameBioMed Central-
local.bibliographicCitation.publisherplaceLondon-
local.bibliographicCitation.doi10.1186/s13019-022-02036-w-
local.openaccesstrue-
dc.identifier.ppn1910590800-
cbs.publication.displayform2022-
local.bibliographicCitation.year2022-
cbs.sru.importDate2024-12-02T12:43:21Z-
local.bibliographicCitationEnthalten in Journal of cardiothoracic surgery - London : BioMed Central, 2006-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s13019-022-02036-w.pdf891.97 kBAdobe PDFThumbnail
View/Open